nodes	percent_of_prediction	percent_of_DWPC	metapath
Vemurafenib—ALB—pancreatitis	0.613	1	CbGaD
Vemurafenib—ORM1—bile—pancreatitis	0.0153	0.328	CbGeAlD
Vemurafenib—Rash papular—Hyoscyamine—pancreatitis	0.00888	0.151	CcSEcCtD
Vemurafenib—Electrocardiogram QT prolonged—Hyoscyamine—pancreatitis	0.00515	0.0876	CcSEcCtD
Vemurafenib—Paralysis—Hyoscyamine—pancreatitis	0.00476	0.081	CcSEcCtD
Vemurafenib—ORM1—gall bladder—pancreatitis	0.00425	0.0911	CbGeAlD
Vemurafenib—RAF1—islet of Langerhans—pancreatitis	0.00404	0.0865	CbGeAlD
Vemurafenib—ALB—gall bladder—pancreatitis	0.00373	0.0799	CbGeAlD
Vemurafenib—BRAF—blood—pancreatitis	0.00347	0.0743	CbGeAlD
Vemurafenib—Etoricoxib—PTGS2—pancreatitis	0.00316	1	CrCbGaD
Vemurafenib—Rash maculo-papular—Hyoscyamine—pancreatitis	0.00301	0.0511	CcSEcCtD
Vemurafenib—RAF1—pancreas—pancreatitis	0.00284	0.0608	CbGeAlD
Vemurafenib—Atrial fibrillation—Hyoscyamine—pancreatitis	0.00253	0.0431	CcSEcCtD
Vemurafenib—RAF1—digestive system—pancreatitis	0.00242	0.0519	CbGeAlD
Vemurafenib—RAF1—blood—pancreatitis	0.00231	0.0495	CbGeAlD
Vemurafenib—Anaphylactic shock—Propantheline—pancreatitis	0.0023	0.0392	CcSEcCtD
Vemurafenib—Dry skin—Hyoscyamine—pancreatitis	0.0022	0.0374	CcSEcCtD
Vemurafenib—Constipation—Propantheline—pancreatitis	0.00197	0.0335	CcSEcCtD
Vemurafenib—Hypersensitivity—Propantheline—pancreatitis	0.0017	0.0289	CcSEcCtD
Vemurafenib—Asthenia—Propantheline—pancreatitis	0.00165	0.0281	CcSEcCtD
Vemurafenib—ORM1—blood—pancreatitis	0.00159	0.0342	CbGeAlD
Vemurafenib—Dizziness—Propantheline—pancreatitis	0.00152	0.0259	CcSEcCtD
Vemurafenib—Vomiting—Propantheline—pancreatitis	0.00147	0.0249	CcSEcCtD
Vemurafenib—Rash—Propantheline—pancreatitis	0.00145	0.0247	CcSEcCtD
Vemurafenib—Dermatitis—Propantheline—pancreatitis	0.00145	0.0247	CcSEcCtD
Vemurafenib—Erythema—Hyoscyamine—pancreatitis	0.00145	0.0246	CcSEcCtD
Vemurafenib—Headache—Propantheline—pancreatitis	0.00144	0.0246	CcSEcCtD
Vemurafenib—Dysgeusia—Hyoscyamine—pancreatitis	0.00142	0.0241	CcSEcCtD
Vemurafenib—Nausea—Propantheline—pancreatitis	0.00137	0.0233	CcSEcCtD
Vemurafenib—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00118	0.0201	CcSEcCtD
Vemurafenib—ABCC1—blood—pancreatitis	0.00115	0.0247	CbGeAlD
Vemurafenib—Hypotension—Hyoscyamine—pancreatitis	0.0011	0.0188	CcSEcCtD
Vemurafenib—Fatigue—Hyoscyamine—pancreatitis	0.00102	0.0173	CcSEcCtD
Vemurafenib—Constipation—Hyoscyamine—pancreatitis	0.00101	0.0172	CcSEcCtD
Vemurafenib—CYP1A2—digestive system—pancreatitis	0.000965	0.0207	CbGeAlD
Vemurafenib—ABCG2—blood—pancreatitis	0.000955	0.0205	CbGeAlD
Vemurafenib—Body temperature increased—Hyoscyamine—pancreatitis	0.000933	0.0159	CcSEcCtD
Vemurafenib—CYP1A2—blood—pancreatitis	0.000919	0.0197	CbGeAlD
Vemurafenib—Hypersensitivity—Hyoscyamine—pancreatitis	0.000869	0.0148	CcSEcCtD
Vemurafenib—Asthenia—Hyoscyamine—pancreatitis	0.000846	0.0144	CcSEcCtD
Vemurafenib—Pruritus—Hyoscyamine—pancreatitis	0.000835	0.0142	CcSEcCtD
Vemurafenib—Diarrhoea—Hyoscyamine—pancreatitis	0.000807	0.0137	CcSEcCtD
Vemurafenib—Dizziness—Hyoscyamine—pancreatitis	0.00078	0.0133	CcSEcCtD
Vemurafenib—Vomiting—Hyoscyamine—pancreatitis	0.00075	0.0128	CcSEcCtD
Vemurafenib—Rash—Hyoscyamine—pancreatitis	0.000744	0.0127	CcSEcCtD
Vemurafenib—Dermatitis—Hyoscyamine—pancreatitis	0.000743	0.0126	CcSEcCtD
Vemurafenib—Headache—Hyoscyamine—pancreatitis	0.000739	0.0126	CcSEcCtD
Vemurafenib—Nausea—Hyoscyamine—pancreatitis	0.000701	0.0119	CcSEcCtD
Vemurafenib—CYP3A4—digestive system—pancreatitis	0.000698	0.015	CbGeAlD
Vemurafenib—CYP2D6—digestive system—pancreatitis	0.000687	0.0147	CbGeAlD
Vemurafenib—CYP3A4—blood—pancreatitis	0.000665	0.0143	CbGeAlD
Vemurafenib—CYP2D6—blood—pancreatitis	0.000655	0.014	CbGeAlD
Vemurafenib—RAF1—Transmission across Chemical Synapses—HRAS—pancreatitis	6.4e-05	0.000229	CbGpPWpGaD
Vemurafenib—ALB—Selenium Micronutrient Network—IL6—pancreatitis	6.35e-05	0.000228	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—ICAM1—pancreatitis	6.34e-05	0.000227	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALDH2—pancreatitis	6.29e-05	0.000226	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PLA2G1B—pancreatitis	6.27e-05	0.000225	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—HRAS—pancreatitis	6.25e-05	0.000224	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SCT—pancreatitis	6.24e-05	0.000224	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CASR—pancreatitis	6.24e-05	0.000224	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGG—pancreatitis	6.24e-05	0.000224	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	6.13e-05	0.00022	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—BDKRB2—pancreatitis	6.13e-05	0.00022	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—KNG1—pancreatitis	6.13e-05	0.00022	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CX3CL1—pancreatitis	6.12e-05	0.00022	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PRSS1—pancreatitis	6.11e-05	0.000219	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—ALB—pancreatitis	6.11e-05	0.000219	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G1B—pancreatitis	6.07e-05	0.000218	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—A2M—pancreatitis	6.05e-05	0.000217	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatitis	6.04e-05	0.000217	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—EGR1—pancreatitis	6.03e-05	0.000216	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CNR1—pancreatitis	6.02e-05	0.000216	CbGpPWpGaD
Vemurafenib—RAF1—NGF signalling via TRKA from the plasma membrane—IL6—pancreatitis	5.98e-05	0.000214	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCK—pancreatitis	5.96e-05	0.000214	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MTNR1B—pancreatitis	5.96e-05	0.000214	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—NRAS—pancreatitis	5.94e-05	0.000213	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NOD2—pancreatitis	5.88e-05	0.000211	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—A2M—pancreatitis	5.87e-05	0.00021	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CD14—pancreatitis	5.85e-05	0.00021	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—GCG—pancreatitis	5.81e-05	0.000209	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TACR1—pancreatitis	5.8e-05	0.000208	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—A2M—pancreatitis	5.8e-05	0.000208	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CNR2—pancreatitis	5.8e-05	0.000208	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PNLIP—pancreatitis	5.8e-05	0.000208	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PRSS3—pancreatitis	5.8e-05	0.000208	CbGpPWpGaD
Vemurafenib—RAF1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—pancreatitis	5.78e-05	0.000207	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—FDX1—pancreatitis	5.78e-05	0.000207	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—KRAS—pancreatitis	5.75e-05	0.000206	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCKAR—pancreatitis	5.71e-05	0.000205	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—KRAS—pancreatitis	5.65e-05	0.000203	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—CTRB2—pancreatitis	5.64e-05	0.000202	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—PDGFA—pancreatitis	5.64e-05	0.000202	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DQA1—pancreatitis	5.63e-05	0.000202	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KNG1—pancreatitis	5.58e-05	0.0002	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALDH2—pancreatitis	5.54e-05	0.000199	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—ALB—pancreatitis	5.52e-05	0.000198	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—PDGFA—pancreatitis	5.49e-05	0.000197	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL5—pancreatitis	5.46e-05	0.000196	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH4—pancreatitis	5.37e-05	0.000193	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGA—pancreatitis	5.31e-05	0.00019	CbGpPWpGaD
Vemurafenib—RAF1—Transmembrane transport of small molecules—ALB—pancreatitis	5.29e-05	0.00019	CbGpPWpGaD
Vemurafenib—ABCC1—Transmembrane transport of small molecules—ALB—pancreatitis	5.24e-05	0.000188	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—XDH—pancreatitis	5.2e-05	0.000186	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—PDGFA—pancreatitis	5.13e-05	0.000184	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—KRAS—pancreatitis	5.12e-05	0.000183	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HGF—pancreatitis	5.11e-05	0.000183	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PDGFA—pancreatitis	5.07e-05	0.000182	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PRSS1—pancreatitis	5.05e-05	0.000181	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PDGFA—pancreatitis	5.03e-05	0.00018	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—MDM2—pancreatitis	4.99e-05	0.000179	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL18—pancreatitis	4.99e-05	0.000179	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HGF—pancreatitis	4.97e-05	0.000178	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SMO—pancreatitis	4.93e-05	0.000177	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PTHLH—pancreatitis	4.93e-05	0.000177	CbGpPWpGaD
Vemurafenib—RAF1—Neuronal System—HRAS—pancreatitis	4.9e-05	0.000176	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—FDX1—pancreatitis	4.89e-05	0.000176	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—HRAS—pancreatitis	4.89e-05	0.000175	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ADH1B—pancreatitis	4.85e-05	0.000174	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—FGB—pancreatitis	4.83e-05	0.000173	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	4.83e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HTR2A—pancreatitis	4.82e-05	0.000173	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—HRAS—pancreatitis	4.8e-05	0.000172	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—MDM2—pancreatitis	4.8e-05	0.000172	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PNLIP—pancreatitis	4.79e-05	0.000172	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PRSS3—pancreatitis	4.79e-05	0.000172	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—GCG—pancreatitis	4.77e-05	0.000171	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PPP3CA—pancreatitis	4.71e-05	0.000169	CbGpPWpGaD
Vemurafenib—RAF1—Cytokine Signaling in Immune system—IL6—pancreatitis	4.68e-05	0.000168	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL5—pancreatitis	4.67e-05	0.000167	CbGpPWpGaD
Vemurafenib—BRAF—Disease—INS—pancreatitis	4.67e-05	0.000167	CbGpPWpGaD
Vemurafenib—ABCG2—Transmembrane transport of small molecules—ALB—pancreatitis	4.62e-05	0.000166	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by NGF—IL6—pancreatitis	4.6e-05	0.000165	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LPL—pancreatitis	4.56e-05	0.000164	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—LPL—pancreatitis	4.56e-05	0.000164	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH4—pancreatitis	4.55e-05	0.000163	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SST—pancreatitis	4.51e-05	0.000162	CbGpPWpGaD
Vemurafenib—RAF1—Disease—LPL—pancreatitis	4.51e-05	0.000162	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—DUSP6—pancreatitis	4.47e-05	0.00016	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—LPL—pancreatitis	4.47e-05	0.00016	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—CTRB2—pancreatitis	4.36e-05	0.000156	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—HRAS—pancreatitis	4.35e-05	0.000156	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—SPP1—pancreatitis	4.32e-05	0.000155	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—XDH—pancreatitis	4.29e-05	0.000154	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PRSS1—pancreatitis	4.28e-05	0.000153	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—BDKRB2—pancreatitis	4.24e-05	0.000152	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—NRAS—pancreatitis	4.24e-05	0.000152	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—GCG—pancreatitis	4.2e-05	0.000151	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—CRP—pancreatitis	4.18e-05	0.00015	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CNR1—pancreatitis	4.16e-05	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Axon guidance—IL6—pancreatitis	4.16e-05	0.000149	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—NRAS—pancreatitis	4.16e-05	0.000149	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HTR2A—pancreatitis	4.11e-05	0.000148	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PRSS3—pancreatitis	4.05e-05	0.000145	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PNLIP—pancreatitis	4.05e-05	0.000145	CbGpPWpGaD
Vemurafenib—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatitis	4.04e-05	0.000145	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—GCG—pancreatitis	4.02e-05	0.000144	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—TLR4—pancreatitis	4.01e-05	0.000144	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HLA-DRB1—pancreatitis	4e-05	0.000144	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ADH1B—pancreatitis	4e-05	0.000144	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TGFB1—pancreatitis	3.94e-05	0.000141	CbGpPWpGaD
Vemurafenib—BRAF—Disease—MDM2—pancreatitis	3.88e-05	0.000139	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PLA2G1B—pancreatitis	3.87e-05	0.000139	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—TGFB1—pancreatitis	3.87e-05	0.000139	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KNG1—pancreatitis	3.86e-05	0.000138	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—ICAM1—pancreatitis	3.84e-05	0.000138	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—LEP—pancreatitis	3.82e-05	0.000137	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—FDX1—pancreatitis	3.78e-05	0.000135	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CCL2—pancreatitis	3.76e-05	0.000135	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—NRAS—pancreatitis	3.75e-05	0.000134	CbGpPWpGaD
Vemurafenib—BRAF—Disease—PTGS2—pancreatitis	3.74e-05	0.000134	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—LPL—pancreatitis	3.74e-05	0.000134	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—A2M—pancreatitis	3.74e-05	0.000134	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—TNF—pancreatitis	3.68e-05	0.000132	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—KRAS—pancreatitis	3.65e-05	0.000131	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—XDH—pancreatitis	3.64e-05	0.00013	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—NRAS—pancreatitis	3.6e-05	0.000129	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—KRAS—pancreatitis	3.58e-05	0.000128	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—PDGFA—pancreatitis	3.55e-05	0.000127	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH4—pancreatitis	3.51e-05	0.000126	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—ALDH2—pancreatitis	3.42e-05	0.000123	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ADH1B—pancreatitis	3.39e-05	0.000122	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	3.33e-05	0.000119	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PRSS1—pancreatitis	3.3e-05	0.000118	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—LPL—pancreatitis	3.29e-05	0.000118	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—INS—pancreatitis	3.27e-05	0.000117	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL5—pancreatitis	3.23e-05	0.000116	CbGpPWpGaD
Vemurafenib—RAF1—Disease—INS—pancreatitis	3.23e-05	0.000116	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—KRAS—pancreatitis	3.22e-05	0.000116	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CCL2—pancreatitis	3.21e-05	0.000115	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—INS—pancreatitis	3.2e-05	0.000115	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PLA2G1B—pancreatitis	3.19e-05	0.000115	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—LPL—pancreatitis	3.19e-05	0.000114	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LPL—pancreatitis	3.16e-05	0.000113	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PNLIP—pancreatitis	3.13e-05	0.000112	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PRSS3—pancreatitis	3.13e-05	0.000112	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—HRAS—pancreatitis	3.1e-05	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—KRAS—pancreatitis	3.1e-05	0.000111	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—A2M—pancreatitis	3.08e-05	0.000111	CbGpPWpGaD
Vemurafenib—RAF1—Hemostasis—HRAS—pancreatitis	3.04e-05	0.000109	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—SPP1—pancreatitis	2.99e-05	0.000107	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—CXCL8—pancreatitis	2.98e-05	0.000107	CbGpPWpGaD
Vemurafenib—RAF1—Developmental Biology—IL6—pancreatitis	2.97e-05	0.000107	CbGpPWpGaD
Vemurafenib—BRAF—Disease—NRAS—pancreatitis	2.91e-05	0.000104	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—MDM2—pancreatitis	2.91e-05	0.000104	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HTR2A—pancreatitis	2.85e-05	0.000102	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALDH2—pancreatitis	2.82e-05	0.000101	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—XDH—pancreatitis	2.81e-05	0.000101	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—HRAS—pancreatitis	2.74e-05	9.83e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PPARG—pancreatitis	2.73e-05	9.8e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—MDM2—pancreatitis	2.72e-05	9.75e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—TGFB1—pancreatitis	2.71e-05	9.7e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PLA2G1B—pancreatitis	2.71e-05	9.7e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—MDM2—pancreatitis	2.69e-05	9.63e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—INS—pancreatitis	2.68e-05	9.61e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—MDM2—pancreatitis	2.66e-05	9.55e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—LEP—pancreatitis	2.65e-05	9.49e-05	CbGpPWpGaD
Vemurafenib—RAF1—Adaptive Immune System—HRAS—pancreatitis	2.63e-05	9.44e-05	CbGpPWpGaD
Vemurafenib—RAF1—Innate Immune System—IL6—pancreatitis	2.62e-05	9.41e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	2.62e-05	9.4e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ADH1B—pancreatitis	2.62e-05	9.39e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—A2M—pancreatitis	2.61e-05	9.37e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL1B—pancreatitis	2.61e-05	9.36e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—GCG—pancreatitis	2.59e-05	9.29e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—PTGS2—pancreatitis	2.59e-05	9.29e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—PTGS2—pancreatitis	2.57e-05	9.21e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CXCL8—pancreatitis	2.54e-05	9.12e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—KRAS—pancreatitis	2.51e-05	8.99e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—ALB—pancreatitis	2.46e-05	8.81e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—CASP3—pancreatitis	2.43e-05	8.72e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PPARG—pancreatitis	2.4e-05	8.62e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALDH2—pancreatitis	2.39e-05	8.57e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—NRAS—pancreatitis	2.39e-05	8.56e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—INS—pancreatitis	2.36e-05	8.46e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatitis	2.33e-05	8.36e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—INS—pancreatitis	2.26e-05	8.11e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—NRAS—pancreatitis	2.24e-05	8.03e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CCL2—pancreatitis	2.22e-05	7.98e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—NRAS—pancreatitis	2.18e-05	7.83e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—ALB—pancreatitis	2.16e-05	7.75e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Metabolism—PTGS2—pancreatitis	2.15e-05	7.71e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—GCG—pancreatitis	2.14e-05	7.67e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—HRAS—pancreatitis	2.13e-05	7.64e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—pancreatitis	2.09e-05	7.51e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PLA2G1B—pancreatitis	2.09e-05	7.49e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—TGFB1—pancreatitis	2.08e-05	7.46e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—KRAS—pancreatitis	2.06e-05	7.37e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—NRAS—pancreatitis	2.04e-05	7.31e-05	CbGpPWpGaD
Vemurafenib—BRAF—Disease—IL6—pancreatitis	2.04e-05	7.31e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—LPL—pancreatitis	2.03e-05	7.29e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—A2M—pancreatitis	2.02e-05	7.23e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—NRAS—pancreatitis	2.01e-05	7.23e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—NRAS—pancreatitis	2e-05	7.16e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—KRAS—pancreatitis	1.93e-05	6.91e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—TGFB1—pancreatitis	1.89e-05	6.8e-05	CbGpPWpGaD
Vemurafenib—ABCG2—Metabolism—PTGS2—pancreatitis	1.89e-05	6.78e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—MDM2—pancreatitis	1.88e-05	6.75e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—KRAS—pancreatitis	1.88e-05	6.74e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—TGFB1—pancreatitis	1.87e-05	6.71e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—TGFB1—pancreatitis	1.86e-05	6.66e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALDH2—pancreatitis	1.84e-05	6.62e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatitis	1.83e-05	6.57e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—GCG—pancreatitis	1.81e-05	6.5e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CXCL8—pancreatitis	1.76e-05	6.31e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—KRAS—pancreatitis	1.75e-05	6.29e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—HRAS—pancreatitis	1.75e-05	6.27e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—KRAS—pancreatitis	1.73e-05	6.22e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—KRAS—pancreatitis	1.72e-05	6.16e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—CASP3—pancreatitis	1.68e-05	6.04e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—LPL—pancreatitis	1.68e-05	6.02e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling by GPCR—IL6—pancreatitis	1.67e-05	6e-05	CbGpPWpGaD
Vemurafenib—ALB—Hemostasis—HRAS—pancreatitis	1.64e-05	5.88e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—HRAS—pancreatitis	1.6e-05	5.73e-05	CbGpPWpGaD
Vemurafenib—RAF1—Immune System—IL6—pancreatitis	1.53e-05	5.48e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—HRAS—pancreatitis	1.49e-05	5.35e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PPARG—pancreatitis	1.48e-05	5.32e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—HRAS—pancreatitis	1.47e-05	5.29e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—HRAS—pancreatitis	1.46e-05	5.24e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—INS—pancreatitis	1.45e-05	5.22e-05	CbGpPWpGaD
Vemurafenib—BRAF—Signaling Pathways—IL6—pancreatitis	1.43e-05	5.12e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—LPL—pancreatitis	1.42e-05	5.1e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—NRAS—pancreatitis	1.41e-05	5.06e-05	CbGpPWpGaD
Vemurafenib—RAF1—Disease—IL6—pancreatitis	1.41e-05	5.06e-05	CbGpPWpGaD
Vemurafenib—ABCC1—Disease—IL6—pancreatitis	1.4e-05	5.01e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—GCG—pancreatitis	1.4e-05	5.01e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—TGFB1—pancreatitis	1.31e-05	4.7e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PPARG—pancreatitis	1.22e-05	4.39e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—KRAS—pancreatitis	1.21e-05	4.35e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—INS—pancreatitis	1.2e-05	4.31e-05	CbGpPWpGaD
Vemurafenib—ALB—Metabolism—PTGS2—pancreatitis	1.17e-05	4.19e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—ALB—pancreatitis	1.1e-05	3.95e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—LPL—pancreatitis	1.1e-05	3.93e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PPARG—pancreatitis	1.04e-05	3.72e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—HRAS—pancreatitis	1.03e-05	3.7e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—INS—pancreatitis	1.02e-05	3.65e-05	CbGpPWpGaD
Vemurafenib—RAF1—Signaling Pathways—IL6—pancreatitis	9.88e-06	3.54e-05	CbGpPWpGaD
Vemurafenib—CYP2D6—Metabolism—PTGS2—pancreatitis	9.63e-06	3.46e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—ALB—pancreatitis	9.33e-06	3.35e-05	CbGpPWpGaD
Vemurafenib—CYP1A2—Metabolism—PTGS2—pancreatitis	8.16e-06	2.93e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PPARG—pancreatitis	8.01e-06	2.87e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—INS—pancreatitis	7.85e-06	2.82e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—ALB—pancreatitis	7.2e-06	2.58e-05	CbGpPWpGaD
Vemurafenib—CYP3A4—Metabolism—PTGS2—pancreatitis	6.3e-06	2.26e-05	CbGpPWpGaD
